Studio osservazionale: “A prospective Registry of patients with a confirmed diagnosis of adenocarcinoma of the prostate presenting with metastatic castrate-resistant prostate cancer”. Protocol 212082PCR4001. Cambio Principal Investigator.

Delibere

DELIBERA n. 350/2018 del 28 Giugno 2018

Studio osservazionale: “A prospective Registry of patients with a confirmed diagnosis of adenocarcinoma of the prostate presenting with metastatic castrate-resistant prostate cancer”. Protocol 212082PCR4001. Cambio Principal Investigator.